Maladies de la jonction neuromusculaire : Questions médicales fréquentes
Nom anglais: Neuromuscular Junction Diseases
Descriptor UI:D020511
Tree Number:C10.668.758
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies de la jonction neuromusculaire : Questions médicales les plus fréquentes",
"headline": "Maladies de la jonction neuromusculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies de la jonction neuromusculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-27",
"dateModified": "2025-03-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies de la jonction neuromusculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies neuromusculaires",
"url": "https://questionsmedicales.fr/mesh/D009468",
"about": {
"@type": "MedicalCondition",
"name": "Maladies neuromusculaires",
"code": {
"@type": "MedicalCode",
"code": "D009468",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.668"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la jonction neuromusculaire",
"alternateName": "Neuromuscular Junction Diseases",
"code": {
"@type": "MedicalCode",
"code": "D020511",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rizwan Qaisar",
"url": "https://questionsmedicales.fr/author/Rizwan%20Qaisar",
"affiliation": {
"@type": "Organization",
"name": "Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Space Medicine Research Group, Sharjah Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; Cardiovascular Research Group, Sharjah Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates. Electronic address: rqaisar@sharjah.ac.ae."
}
},
{
"@type": "Person",
"name": "Asima Karim",
"url": "https://questionsmedicales.fr/author/Asima%20Karim",
"affiliation": {
"@type": "Organization",
"name": "Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "David Lacomis",
"url": "https://questionsmedicales.fr/author/David%20Lacomis",
"affiliation": {
"@type": "Organization",
"name": "Departments of Neurology and Pathology (Neuropathology), University of Pittsburgh School of Medicine, Pittsburgh, PA; and."
}
},
{
"@type": "Person",
"name": "Ines Boehm",
"url": "https://questionsmedicales.fr/author/Ines%20Boehm",
"affiliation": {
"@type": "Organization",
"name": "Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK."
}
},
{
"@type": "Person",
"name": "Ross A Jones",
"url": "https://questionsmedicales.fr/author/Ross%20A%20Jones",
"affiliation": {
"@type": "Organization",
"name": "Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies neuromusculaires",
"item": "https://questionsmedicales.fr/mesh/D009468"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies de la jonction neuromusculaire",
"item": "https://questionsmedicales.fr/mesh/D020511"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies de la jonction neuromusculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies de la jonction neuromusculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies de la jonction neuromusculaire",
"description": "Comment diagnostique-t-on une maladie de la jonction neuromusculaire ?\nQuels tests sont utilisés pour évaluer la force musculaire ?\nLes anticorps sont-ils importants dans le diagnostic ?\nQuelle imagerie est utilisée pour ces maladies ?\nLes tests génétiques sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies de la jonction neuromusculaire",
"description": "Quels sont les symptômes courants de ces maladies ?\nLa fatigue musculaire est-elle un symptôme fréquent ?\nLes troubles de la vision peuvent-ils survenir ?\nLes symptômes varient-ils selon l'âge ?\nLes symptômes sont-ils constants ou fluctuants ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies de la jonction neuromusculaire",
"description": "Peut-on prévenir les maladies de la jonction neuromusculaire ?\nLes vaccinations peuvent-elles aider ?\nUn mode de vie sain peut-il réduire les risques ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il aggraver les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies de la jonction neuromusculaire",
"description": "Quels traitements sont disponibles pour ces maladies ?\nLa plasmaphérèse est-elle utilisée ?\nLes corticostéroïdes sont-ils efficaces ?\nLa rééducation est-elle importante ?\nY a-t-il des traitements expérimentaux ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies de la jonction neuromusculaire",
"description": "Quelles sont les complications possibles ?\nLes complications peuvent-elles être graves ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles survenir rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies de la jonction neuromusculaire",
"description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nLes infections peuvent-elles déclencher ces maladies ?\nLe tabagisme est-il un facteur de risque ?\nL'exposition à des toxines est-elle préoccupante ?",
"url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une maladie de la jonction neuromusculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests électromyographiques et des analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la force musculaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de force manuelle et des évaluations fonctionnelles sont réalisés."
}
},
{
"@type": "Question",
"name": "Les anticorps sont-ils importants dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la détection d'anticorps spécifiques aide à confirmer certaines maladies."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utilisée pour ces maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut être utilisée pour évaluer les muscles et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être utiles pour identifier des formes héréditaires de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de ces maladies ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, fatigue et difficultés à avaler."
}
},
{
"@type": "Question",
"name": "La fatigue musculaire est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue s'aggrave souvent avec l'activité physique prolongée."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision peuvent-ils survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes oculaires comme la ptose peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge d'apparition et la gravité des symptômes peuvent varier."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils constants ou fluctuants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent fluctuer, s'aggravant après des efforts ou en fin de journée."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies de la jonction neuromusculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas ces maladies, mais protègent contre d'autres infections."
}
},
{
"@type": "Question",
"name": "Un mode de vie sain peut-il réduire les risques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut améliorer la santé générale, mais ne prévient pas ces maladies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains facteurs environnementaux peuvent influencer le développement de ces maladies."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les symptômes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ces maladies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments immunosuppresseurs et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "La plasmaphérèse est-elle utilisée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à réduire les symptômes en éliminant les anticorps nocifs."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent améliorer la force musculaire et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle importante ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation physique aide à maintenir la force et la fonction musculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des traitements ciblés sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des difficultés respiratoires et des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent mettre en danger la vie, nécessitant une attention urgente."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont gérées par des soins médicaux appropriés et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent réduire la qualité de vie et nécessiter des adaptations."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir rapidement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent se développer rapidement, nécessitant une surveillance étroite."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et l'âge."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies de la jonction neuromusculaire sont plus fréquentes chez les femmes."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher ces maladies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent précipiter l'apparition de ces maladies."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque de développer des maladies neuromusculaires."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle préoccupante ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut être un facteur de risque."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....